CDH11 and metastatic neoplasm: The observation that in cultured cells, and potentially in vivo, high Src levels downregulate Cad11, which, in turn, may be required for metastasis, especially to the bone, may signify that actual metastatic tumors cannot possibly express such high Src levels as to eliminate Cad11.